Welcome to our dedicated page for Corteva SEC filings (Ticker: CTVA), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Corteva, Inc. filings document the reporting obligations of a NYSE-listed agriculture company with common stock registered under the Exchange Act. Form 8-K reports cover quarterly and annual operating results, furnished earnings releases, financial statement schedules, annual meeting voting results, executive officer changes, board matters, dividend-related disclosures, and strategic separation planning for its agriculture businesses.
The company's definitive proxy materials provide governance and compensation disclosures, including director elections, shareholder proposals, executive compensation tables, equity awards, board oversight, and stockholder voting matters. Corteva's filing record also identifies its capital structure, including common stock and preferred stock matters involving EIDP, Inc., a wholly owned subsidiary.
Corteva, Inc. director David C. Everitt reported an acquisition of 2,350 shares of common stock as a grant or award, with no purchase price per share shown. This is a compensation-related stock award rather than an open-market purchase.
The filing notes that the total includes 158.0986 shares acquired through dividend reinvestment, bringing his directly owned position to 19,738.3965 shares after the transaction. This reflects a modest increase in his equity stake in the company.
Corteva, Inc. director Pat Ward reported routine equity compensation and updated holdings. Ward received a grant or award of 2,350 shares of Corteva common stock at a stated price of $0.00 per share, increasing direct ownership to 38,432.3983 shares.
The filing also shows 1 share of common stock held indirectly by Ward’s spouse. A footnote explains that these holdings include the acquisition of 324.7033 shares pursuant to dividend reinvestment, reflecting automatic share accumulation rather than open‑market buying.
Corteva, Inc. director Kerry J. Preete reported a stock award of 2,350 shares of Corteva common stock on April 28, 2026, recorded as a grant, award, or other acquisition at no cash cost per share. After this award, Preete directly holds 18,467.3965 Corteva shares. The filing also reports 2,500 Corteva shares held indirectly in a revocable living trust. A footnote states that the reported acquisition includes 158.0986 shares received through dividend reinvestment.
Policinski Christopher J. reported acquisition or exercise transactions in this Form 4 filing.
Corteva, Inc. director Christopher J. Policinski received a grant of 2,350 shares of Corteva common stock on April 28, 2026. The shares were awarded at a stated price of $0.0000 per share, indicating a compensation-related grant rather than a market purchase. After this award, he directly owns 2,350 Corteva common shares.
Corteva, Inc. director Nayyar Nayaki R reported acquiring common stock through a compensation-related award. On this Form 4, the insider received 2,350 shares of Corteva common stock at a stated price of $0.0000 per share, described as a grant or award.
Following this transaction, the director directly holds a total of 35,853.3934 shares of Corteva common stock. A related footnote explains that the total includes the acquisition of 76.1249 shares through dividend reinvestment, indicating part of the position increased automatically as dividends were reinvested rather than through open-market purchases.
Corteva, Inc. director Marcos M. Lutz reported an acquisition of company stock through a grant or award. On April 28, 2026, he was granted 2,350 shares of Common Stock at a reported price of $0.0000 per share, indicating a compensation-related share award rather than a market purchase.
After this transaction, his direct holdings increased to 63,959.0864 shares of Corteva common stock. A footnote explains that this amount includes the acquisition of 199.7943 shares attributed to dividend reinvestment, showing that part of the position growth came from automatically reinvested dividends.
Corteva, Inc. director Karen H. Grimes reported an acquisition of common stock as part of her compensation. She received a grant of 2,350 shares of Corteva common stock at no stated purchase price. The filing notes that this figure includes the acquisition of 68.7043 shares through dividend reinvestment, meaning a portion of the award came from automatically reinvested dividends.
Following this grant and associated dividend reinvestment, Grimes’ direct holdings increased to 18,272.0829 shares of Corteva common stock. This was a routine grant or award acquisition reported on a Form 4, not an open-market purchase.
Corteva, Inc. director Janet Plaut Giesselman reported receiving a grant of 2,350 shares of Common Stock at no cost. This compensation-related award increased her direct holdings to 20,006.9028 shares of Corteva stock. A footnote notes that this amount includes 39.0792 shares acquired through dividend reinvestment, reflecting automatic reinvestment of dividends rather than open-market buying.
Corteva, Inc. director Jean-Marc Gilson received a grant of 2,350 shares of Common Stock as compensation. The shares were acquired at a stated price of $0.00 per share, indicating this was an award rather than an open-market purchase. Following this grant, Gilson directly holds 2,350 shares of Corteva Common Stock.
Corteva, Inc. director Klaus A. Engel reported receiving an award of 2,350 shares of Common Stock on April 28, 2026. This was a grant or other acquisition at no stated purchase price. The filing notes that the total includes 207.3757 shares acquired through dividend reinvestment. After this award, Engel directly holds 41,124.9582 shares of Corteva common stock.